Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor

Neil Eccles, Mircea Ivan, David Wynford-Thomas

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Hepatocyte growth factor (HGF) has been shown to be mitogenic for a wide variety of epithelial cells, including recently, dog thyroid follicular cells. Here we have extended this work to human thyrocytes, and find that recombinant HGF stimulates DNA synthesis (proportion of cells in cell cycle S phase) in normal primary cells in monolayer, with an ED50 of ~ 8 ng/ml and a maximum between 50 and 250 ng/ml. Stimulation was observed even in the presence of 10% fetal calf serum (previously the most potent mitogen for these cells in our hands), the maximum nuclear 3H-thymidine labelling index achieved with HGF being up to 6-fold higher than that with serum alone. A similar additive effect was observed on thyrocytes already stimulated to proliferate by expression of an activated ret oncogene. These results make HGF the most potent defined mitogen for human thyrocytes to date, and suggest that upregulated HGF/met signalling may confer a significant growth advantage even in neoplastic thyroid cells, consistent with the finding of increased met expression in many thyroid carcinomas.

Original languageEnglish (US)
Pages (from-to)247-251
Number of pages5
JournalMolecular and Cellular Endocrinology
Volume117
Issue number2
DOIs
StatePublished - Mar 25 1996
Externally publishedYes

Fingerprint

Hepatocyte Growth Factor
Oncogenes
Mitogens
Serum
S Phase
Thyroid Neoplasms
Thymidine
Labeling
Monolayers
Cell Cycle
Thyroid Gland
Epithelial Cells
Cells
Thyroid Epithelial Cells
Dogs
DNA
Growth

Keywords

  • Epithelium
  • HGF
  • Met
  • Ret
  • Thyroid

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor. / Eccles, Neil; Ivan, Mircea; Wynford-Thomas, David.

In: Molecular and Cellular Endocrinology, Vol. 117, No. 2, 25.03.1996, p. 247-251.

Research output: Contribution to journalArticle

@article{5edf867c9c3d42bd863177c959bca0e5,
title = "Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor",
abstract = "Hepatocyte growth factor (HGF) has been shown to be mitogenic for a wide variety of epithelial cells, including recently, dog thyroid follicular cells. Here we have extended this work to human thyrocytes, and find that recombinant HGF stimulates DNA synthesis (proportion of cells in cell cycle S phase) in normal primary cells in monolayer, with an ED50 of ~ 8 ng/ml and a maximum between 50 and 250 ng/ml. Stimulation was observed even in the presence of 10{\%} fetal calf serum (previously the most potent mitogen for these cells in our hands), the maximum nuclear 3H-thymidine labelling index achieved with HGF being up to 6-fold higher than that with serum alone. A similar additive effect was observed on thyrocytes already stimulated to proliferate by expression of an activated ret oncogene. These results make HGF the most potent defined mitogen for human thyrocytes to date, and suggest that upregulated HGF/met signalling may confer a significant growth advantage even in neoplastic thyroid cells, consistent with the finding of increased met expression in many thyroid carcinomas.",
keywords = "Epithelium, HGF, Met, Ret, Thyroid",
author = "Neil Eccles and Mircea Ivan and David Wynford-Thomas",
year = "1996",
month = "3",
day = "25",
doi = "10.1016/0303-7207(95)03757-8",
language = "English (US)",
volume = "117",
pages = "247--251",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor

AU - Eccles, Neil

AU - Ivan, Mircea

AU - Wynford-Thomas, David

PY - 1996/3/25

Y1 - 1996/3/25

N2 - Hepatocyte growth factor (HGF) has been shown to be mitogenic for a wide variety of epithelial cells, including recently, dog thyroid follicular cells. Here we have extended this work to human thyrocytes, and find that recombinant HGF stimulates DNA synthesis (proportion of cells in cell cycle S phase) in normal primary cells in monolayer, with an ED50 of ~ 8 ng/ml and a maximum between 50 and 250 ng/ml. Stimulation was observed even in the presence of 10% fetal calf serum (previously the most potent mitogen for these cells in our hands), the maximum nuclear 3H-thymidine labelling index achieved with HGF being up to 6-fold higher than that with serum alone. A similar additive effect was observed on thyrocytes already stimulated to proliferate by expression of an activated ret oncogene. These results make HGF the most potent defined mitogen for human thyrocytes to date, and suggest that upregulated HGF/met signalling may confer a significant growth advantage even in neoplastic thyroid cells, consistent with the finding of increased met expression in many thyroid carcinomas.

AB - Hepatocyte growth factor (HGF) has been shown to be mitogenic for a wide variety of epithelial cells, including recently, dog thyroid follicular cells. Here we have extended this work to human thyrocytes, and find that recombinant HGF stimulates DNA synthesis (proportion of cells in cell cycle S phase) in normal primary cells in monolayer, with an ED50 of ~ 8 ng/ml and a maximum between 50 and 250 ng/ml. Stimulation was observed even in the presence of 10% fetal calf serum (previously the most potent mitogen for these cells in our hands), the maximum nuclear 3H-thymidine labelling index achieved with HGF being up to 6-fold higher than that with serum alone. A similar additive effect was observed on thyrocytes already stimulated to proliferate by expression of an activated ret oncogene. These results make HGF the most potent defined mitogen for human thyrocytes to date, and suggest that upregulated HGF/met signalling may confer a significant growth advantage even in neoplastic thyroid cells, consistent with the finding of increased met expression in many thyroid carcinomas.

KW - Epithelium

KW - HGF

KW - Met

KW - Ret

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=0029924321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029924321&partnerID=8YFLogxK

U2 - 10.1016/0303-7207(95)03757-8

DO - 10.1016/0303-7207(95)03757-8

M3 - Article

VL - 117

SP - 247

EP - 251

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 2

ER -